During the past decade, St. Georg Klinikum Eisenach GmbH conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Georg Klinikum Eisenach GmbH" #1 sponsor was "German CLL Study Group" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Center for Sepsis Control and Care, Germany" with 1 trials sponsored, "IHF GmbH - Institut für Herzinfarktforschung" with 1 trials sponsored and "Ipsen" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Georg Klinikum Eisenach GmbH" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Israeli CLL Study Group" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "St. Georg Klinikum Eisenach GmbH" are "Chronic Lymphocytic Leukemia" (2 trials), "Advanced or Metastatic Renal Cell Carcinoma" (1 trials), "Breast Neoplasms" (1 trials), "Carcinoma, Renal Cell" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "St. Georg Klinikum Eisenach GmbH" in a lesser frequency.

Most popular intervention types in "St. Georg Klinikum Eisenach GmbH" are "Drug" (6 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Fludarabine" (2 trials), "Rituximab" (2 trials), "5FU/LV, Oxaliplatin, Bevacizumab, Irinotecan" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Georg Klinikum Eisenach GmbH" are 10 trials for "All" genders.

Currently, there are NaN active trials in "St. Georg Klinikum Eisenach GmbH". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in St. Georg Klinikum Eisenach GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St. Georg Klinikum Eisenach GmbH, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".